Background

Fungal infections are caused by various types of fungi. These infections can affect different parts of the body, including the skin, nails, hair, lungs, and internal organs. Fungal infections can range from mild and localized to severe and potentially life-threatening, depending on the type of fungus involved and the patient’s immune system status. 

Athlete’s Foot: This common fungal infection affects the feet and is characterized by itchy, red, and peeling skin between the toes and on the soles of the feet. 

Ringworm (Tinea Corporis): Ringworm is a fungal infection that causes red, circular rashes on the skin, not necessarily caused by a worm. It can affect various parts of the body. 

Cutaneous Fungal Infections: 

Onychomycosis: This is a fungal infection of the nails, commonly affecting the toenails. It can cause thickening, discoloration, and crumbling of the nails. 

Mucocutaneous Fungal Infections: 

Candidiasis: Caused by Candida species, candidiasis can affect the mouth (oral thrush), genital area (vaginal yeast infection), and other mucous membranes. 

Respiratory Fungal Infections: 

Aspergillosis: This is caused by the Aspergillus fungus and can affect the lungs and sometimes other organs. It is more common in people with weakened immune systems. 

Systemic Fungal Infections: 

Candidemia: This is a bloodstream infection caused by Candida species. It often occurs in individuals with compromised immune systems or those who have undergone extensive medical procedures. 

Cryptococcosis: Cryptococcus neoformans is responsible for this infection, which primarily affects the lungs but can also involve the central nervous system. 

Epidemiology

The prevalence and types of fungal infections can vary significantly by geographic region. Many fungal infections are considered opportunistic thus, they primarily affect individuals with weakened immune systems.  

These include people with HIV, cancer patients undergoing chemotherapy, organ transplant recipients on immunosuppressive medications, and those with other immunocompromising conditions. 

Fungal infections are more prevalent than others. These include candidiasis, aspergillosis, and cryptococcosis. Candida species are common causes of mucosal and bloodstream infections, while Aspergillus species are often associated with respiratory and lung infections. Cryptococcus neoformans can cause meningitis and other serious infections, particularly in immunocompromised individuals. 

Anatomy

Pathophysiology

The entry route can vary depending on the type of fungus. Common entry points include the respiratory tract, the skin, and mucous membranes (e.g., the oral cavity or genitalia). Fungal cells may then adhere to host tissues. 

The host’s immune system plays a critical role in defending against fungal infections. Both the innate and adaptive immune responses are activated. In the early stages, neutrophils and macrophages are often the first line of defense against fungal invaders. These immune cells engulf and attempt to destroy the fungi. Fungi have evolved various mechanisms to evade the host’s immune system.  

In the presence of an effective immune response, the host can generate antifungal immunity. This involves the activation of T cells and the production of specific antibodies that can help control and clear fungal infection. Vaccination strategies for certain fungal pathogens aim to enhance this antifungal immunity. 

Some fungal infections can become chronic, with fungi persisting within host tissues for extended periods. These chronic infections may have periods of dormancy and reactivation, especially in individuals with impaired immune function. 

Etiology

The primary cause of fungal infections is the presence of pathogenic fungi. These fungi can belong to different genera and species. Common fungal pathogens in humans include Candida species, Aspergillus species, Cryptococcus neoformans, dermatophytes, Histoplasma capsulatum, and many others. 

The susceptibility of an individual to fungal infections is influenced by host factors. These can include age, sex, genetics, underlying health conditions, and immune status. Immunocompromised individuals, such as those with HIV, cancer patients undergoing chemotherapy, or organ transplant recipients taking immunosuppressive drugs, are more vulnerable to fungal infections. 

A functioning immune system is crucial in preventing fungal infections. Neutrophils, macrophages, and other components of the immune system play a role in recognizing and eliminating fungal invaders. Defects in the immune system, as seen in conditions like severe combined immunodeficiency (SCID), can lead to increased susceptibility to fungal infections. 

The environment can be a source of fungal pathogens. Inhalation of airborne fungal spores, contact with contaminated soil, or exposure to mold in indoor environments can introduce fungi to the host and lead to infections. 

Skin serves as a barrier against fungal infections. Breaks in the skin, such as cuts, abrasions, or burns, can provide an entry point for fungi. Warm and moist environments can also encourage fungal growth on the skin. 

Genetics

Prognostic Factors

The specific fungal species causing the infection can significantly impact the prognosis. Some fungi are inherently more virulent and difficult to treat than others.  

The overall health and immune status of the affected individual are crucial prognostic factors. Immunocompromised individuals, such as those with HIV, cancer patients undergoing chemotherapy, or organ transplant recipients on immunosuppressive medications, are at higher risk of severe fungal infections with worse prognoses. 

The degree of immunosuppression matters. Individuals with severe and prolonged immunosuppression are at greater risk of severe fungal infections.  

The location and extent of the fungal infection within the body are critical factors. Superficial fungal infections generally have a better prognosis compared to invasive or disseminated infections that involve internal organs (e.g., lungs, brain, blood). 

Clinical History

Superficial fungal infections, such as candidal dermatitis, oral thrush (candidiasis), and tinea infections (ringworm), are relatively common in infants and young children. 

Paediatric patients, especially those with leukaemia or congenital immunodeficiencies, may be at risk of invasive fungal infections. 

Adolescents and young adults can experience fungal skin infections, such as athlete’s foot (tinea pedis) and fungal nail infections (onychomycosis). 

Fungal skin infections continue to affect adults, including ringworm, jock itch (tinea cruris), and athlete’s foot. 

Physical Examination

• General Examination: Evaluate the patient’s overall appearance, vital signs (e.g., temperature, heart rate, and respiratory rate), and any signs of systemic illness, such as fever, malaise, or weight loss. This is particularly important for invasive or systemic fungal infections. 
• Skin Examination: Examine the skin for any rash, redness, scaling, itching, or discoloration, which may indicate superficial fungal infections like ringworm or candidiasis. 

Examine the nails for changes in color, texture, or thickness, as these may be indicative of fungal nail infections (onychomycosis). 

• Oral Examination: Examine the mouth, tongue, and oral mucosa for signs of white patches or lesions, which could suggest oral candidiasis. 
• Lymph Nodes: Palpate the lymph nodes, particularly in the neck, axilla, and groin, to check for enlargement, which may occur in response to a localized or disseminated fungal infection. 
• Genital and Anal Examination: Examine the genital and anal areas for rashes, itching, discharge, or other symptoms that may suggest fungal infections, such as vaginal candidiasis or jock itch. 
• Assessment of Nail and Hair: In cases of suspected fungal nail or hair infections, examine the nails and scalp for characteristic changes such as separation of the nail plate from the nail bed or alopecia. 

Age group

Associated comorbidity

• Immunosuppression: Weakened immune function is a major risk factor for fungal infections.  
• Diabetes: People with diabetes, especially when poorly controlled, are at an increased risk of fungal infections. They are prone to mucocutaneous candidiasis, fungal skin infections, and invasive fungal infections. 
• Chronic Respiratory Diseases: Certain respiratory conditions, such as chronic obstructive pulmonary disease (COPD) and asthma, can increase the risk of fungal lung infections, including aspergillosis and fungal exacerbations of underlying lung disease. 
• Cystic Fibrosis: Individuals with cystic fibrosis are at a higher risk of lung infections, including those caused by Aspergillus and other fungi. 
• Severe Combined Immunodeficiency (SCID): Infants born with SCID have profound immune system deficiencies, making them highly susceptible to a wide range of infections, including fungal pathogens. 
• Chronic Granulomatous Disease (CGD): This rare genetic disorder affects the body’s ability to fight infections, including fungal ones. People with CGD are susceptible to chronic and severe fungal infections. 
• Asthma and Allergies: Allergic bronchopulmonary aspergillosis (ABPA) is a fungal infection that can complicate asthma and allergic reactions to Mold spores. 
• Malnutrition: Poor nutrition can weaken the immune system, making individuals more susceptible to fungal infections, especially in developing countries. 

Associated activity

Acuity of presentation

Fungal infections, particularly those caused by invasive fungal pathogens like Aspergillus, Candida, and Mucorales, can present acutely and progress rapidly. These infections may cause severe symptoms, such as high fever, rapid onset of organ dysfunction, and a fulminant clinical course. 

Cryptococcal meningitis, caused by Cryptococcus neoformans, can have an acute presentation with symptoms like severe headaches, altered mental status, and fever. 

Fungal lung infections, such as aspergillosis or histoplasmosis, may present with subacute respiratory symptoms, including cough, shortness of breath, and fever. These infections can progress over weeks to months. 

In immunocompromised individuals, systemic candidiasis may have a subacute presentation with symptoms such as fever, chills, and persistent candidemia. 

Fungal infections of the skin, hair, and nails (e.g., tinea infections, onychomycosis) often have a chronic presentation, with slowly progressing symptoms, such as itching, scaling, and discoloration. 

Conditions like chronic pulmonary aspergillosis may present with persistent respiratory symptoms, cough, and weight loss over an extended period. 

Chronic mucocutaneous candidiasis, a genetic disorder, presents with recurrent and persistent Candida infections of the skin, nails, and mucous membranes. 

Differential Diagnoses

• Viral Infections: Herpes simplex virus (HSV) or varicella-zoster virus (VZV) can cause skin lesions that resemble fungal infections. 
• Psoriasis: Psoriasis can lead to scaly, red patches on the skin, nails, and scalp, which may resemble fungal conditions like psoriasis. 
• Eczema (Dermatitis): Eczema can result in itchy, red, and inflamed skin, like fungal infections. Both conditions may lead to skin fissures and secondary bacterial infections. 
• Autoimmune Diseases: Autoimmune disorders like lupus erythematosus or dermatomyositis can manifest with skin rashes and systemic symptoms. 
• Lice and Parasitic Infections: Infestations with lice, bedbugs, or other parasites can cause skin irritation and itching. 

• Malignant Conditions: Skin cancers, such as basal cell carcinoma and squamous cell carcinoma, can present as persistent skin lesions that may be mistaken for chronic fungal infections. 

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

• Identification of Fungal Pathogen: Accurate identification of the fungal pathogen is essential. This may involve clinical evaluation, fungal cultures, and microscopy. 
• Antifungal Medications: Antifungal drugs are the primary treatment for fungal infections.  
• Topical Antifungals: For superficial fungal infections of the skin, nails, and mucous membranes, topical antifungal creams, ointments, powders, and solutions may be prescribed. Common agents include clotrimazole, miconazole, and terbinafine. 
• Systemic Antifungal Agents: Systemic antifungal agents are used for severe or disseminated fungal infections, as well as for certain superficial infections that are difficult to treat topically. 
• Follow-Up and Monitoring: Patients should be closely monitored to assess treatment response and potential side effects of antifungal medications.

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

use-of-non-pharmacological-approach-for-fungal-infections

• Control Humidity and Moisture: Many fungi thrive in damp and humid environments. Use dehumidifiers in areas prone to excess moisture, such as basements, bathrooms, and kitchens. 
• Proper Supply of Ventilation: Ensure adequate ventilation in areas with moisture, such as bathrooms and kitchens. Proper ventilation helps reduce humidity and prevents the growth of molds. 
• Reduce Clutter: Reducing clutter in living spaces can improve airflow and make it easier to clean and maintain a fungal-free environment. Clutter can provide hiding places for mold and other fungi. 
• Proper Storage: Store items in well-ventilated areas to prevent moisture buildup. Avoid storing items directly on the floor or in damp basements, as these locations are more susceptible to fungal contamination. 
• Mold-Resistant Building Materials: Consider using mold-resistant building materials, paints, and drywall in areas where moisture may be an issue, such as bathrooms and kitchens. 
• Regular Cleaning: Clean and dust living spaces regularly, especially in areas where dust can accumulate. Dust can harbor mold spores and other allergens. 
• Air Purifiers: High-efficiency particulate air (HEPA) filters can help remove fungal spores and other airborne particles. Consider using air purifiers in bedrooms and living areas, especially for individuals with respiratory conditions. 

• Regular Inspections for Moisture and Leaks: Periodically inspect the building for signs of water damage, roof leaks, and plumbing leaks, and address them promptly. 

Use of Azoles drugs

Fluconazole and Voriconazole are antifungal medications that play important roles in the treatment of fungal infections. These drugs belong to the azole class. 

• Fluconazole: Fluconazole is a broad-spectrum antifungal agent that is effective against a variety of fungal pathogens, including Candida species (e.g., Candida albicans), some Cryptococcus species, and certain dermatophytes. It is used to treat Candida infections, especially mucocutaneous candidiasis and candidemia. 
• Voriconazole: Voriconazole has a broader spectrum of activity compared to fluconazole and is effective against a wider range of fungal pathogens, including Candida species, Aspergillus species, and certain rare Molds. It is particularly useful for invasive Mold infections. 

Role of Echinocandins

Echinocandins are a class of antifungal medications that play an important role in the treatment of fungal infections, particularly those caused by certain Candida and Aspergillus species.  

Echinocandins work by inhibiting the synthesis of fungal cell walls, leading to fungal cell death.  

• Caspofungin: It is commonly used as a first-line agent for the treatment of invasive candidiasis, a serious bloodstream infection caused by Candida species. It is effective against a wide range of Candida strains, including some that may be resistant to other antifungal classes. 

Role of Polyenes

Amphotericin B: It is a first-line treatment for invasive fungal infections caused by a variety of fungal species, including Candida, Aspergillus, Cryptococcus, and certain Molds. It is particularly effective against infections that are resistant to other antifungal agents. 

Amphotericin B is used to treat systemic fungal infections that have spread throughout the body, such as disseminated candidiasis, invasive aspergillosis, and cryptococcal meningitis. 

It is used as treatment option for fungal infections involving the central nervous system, including fungal meningitis caused by Cryptococcus. 

Role of other antifungals

Flucytosine: It is known as 5-fluorocytosine, is primarily used in combination with other antifungal agents to treat specific fungal infections, notably those caused by Cryptococcus species, including Cryptococcus neoformans. 

It is often used as part of combination therapy for severe fungal infections, particularly cryptococcal meningitis. 

Flucytosine is converted to 5-fluorouracil (5-FU) by fungal cytosine deaminase. Once converted, 5-FU disrupts fungal RNA and DNA synthesis, interfering with fungal cell growth and replication. 

Fluconazole: It interferes with the fungal cell membrane by inhibiting the synthesis of ergosterol, a vital component of fungal cell walls. This disruption weakens the fungal cell membrane and leads to cell death. 

Drugs used in Oral and Vaginal Candidiasis

Nystatin: Nystatin is primarily used to treat superficial fungal infections, particularly those caused by Candida species. It is commonly indicated in cases of oral and intestinal candidiasis, as well as cutaneous (skin) infections like diaper rash or fungal skin infections. 

Nystatin is available in various topical forms, including creams, ointments, and oral suspensions. 

Clotrimazole: Clotrimazole is used to treat a range of superficial fungal infections, including those caused by Candida species, dermatophytes, and other fungi. It is commonly employed for conditions like vaginal yeast infections (vulvovaginal candidiasis), jock itch, athlete’s foot, and ringworm. 

Clotrimazole is available in various topical formulations, including creams, ointments, and solutions. These are applied directly to the affected area of the skin or mucous membranes. 

use-of-intervention-with-a-procedure-in-treating-fungal-infections

• Fungal Culture Testing: Fungal cultures involve collecting samples from the infected site to identify the causative fungus and determine its susceptibility to specific antifungal medications. This information guides treatment decisions. 
• Biopsy: In cases of invasive or deep-seated fungal infections, a biopsy may be performed to obtain tissue samples for histological examination. This can help confirm the presence of fungal elements and guide treatment. 
• Aspiration: For abscesses or collections of infected fluid (e.g., lung abscess, liver abscess), drainage or aspiration may be necessary to remove pus or infected material and provide relief from symptoms. 
• Surgical Debridement: In cases of fungal infections involving skin and soft tissues, surgical debridement may be required to remove necrotic tissue and control the spread of infection. 
• Bronchoscopy: Invasive pulmonary fungal infections may necessitate bronchoscopy, a procedure in which a thin, flexible tube is inserted into the airways to collect samples, obtain biopsies, and visually inspect the respiratory tract. 
• Lumbar Puncture: Lumbar puncture (spinal tap) may be performed to collect cerebrospinal fluid (CSF) for examination in cases of suspected fungal meningitis or central nervous system infections. 

use-of-phases-in-managing-fungal-infections

Assessment and Diagnosis Phase: The first phase involves a thorough evaluation of the patient’s medical history, clinical presentation, and physical examination to determine the likelihood of a fungal infection. 

Diagnostic tests, such as fungal cultures, microscopy, serological tests, and imaging studies, are used to identify the causative fungus, the location and extent of the infection, and the patient’s immune status. 

Selection of Antifungal Treatment: Based on the identified fungal pathogen, the location of the infection, and the patient’s clinical condition, healthcare providers select an appropriate antifungal treatment. The choice of antifungal agent may involve consideration of susceptibility testing and drug interactions. 

Monitoring and Follow-Up Phase: Patients are closely monitored throughout the treatment phase to assess their clinical response, potential side effects of antifungal drugs, and the resolution of the infection. 

Supportive Measures: Depending on the severity of the infection and the patient’s overall health, adjunctive care and supportive measures may be provided. These can include pain management, wound care, and treatment of complications associated with the infection. 

Education and Patient Counselling Phase: Patients and their caregivers are educated about the nature of the fungal infection, the importance of medication adherence, and the signs of treatment failure or relapse. 

Medication

Future Trends

Media Gallary

References

Fungal infections: Pathogenesis, antifungals and alternate treatment approaches – ScienceDirect 

What Are Fungal Infections? – PMC (nih.gov) 

Fungal Infection (researchgate.net)